TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 3 | -1 | -2 | -1 | -9 | -6 | -12 | -5 |
| S | %wins | 100 | 100 | 100 | 67 | 33 | 67 | 78 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/10/20 18:25 | 2/6/20 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Wold Olsen Per | CA | D | S.dm | -2,879 | 68.55 | 0 | -42 | -30 | 98 | D | |||||||||||||||
8/29/19 16:42 | 8/28/19 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Wold Olsen Per | CA | D | S.d | -314 | 63.91 | 0 | -5 | -5 | 98 | D | |||||||||||||||
2/17/06 12:02 | 2/16/06 | MRK | Merck & Co Inc | NJ | Health | Drug | Pharmaceutical Preparations | Wold Olsen Per | NJ | O | P,HH Int | S.d | -3,325 | 35.02 | 33 | -95 | -35 | 180 | B | -1 | -2 | 0 | -1 | 10 | 29 | ||||||||
8/4/04 14:15 | 8/3/04 | MRK | Merck & Co Inc | NJ | Health | Drug | Pharmaceutical Preparations | Wold Olsen Per | NJ | O | P,HH,Eur | S.d | -2,996 | 45.12 | 33 | -66 | -27 | 180 | D | 5 | -10 | -5 | -5 | -6 | -2 | -1 | -1 | 0 | 0 | 0 | -36 | -37 | -28 |
11/4/03 13:38 | 11/3/03 | MRK | Merck & Co Inc | NJ | Health | Drug | Pharmaceutical Preparations | Wold Olsen Per | NJ | O | P,HH,Eur | S | -1,973 | 44.75 | 33 | -44 | -34 | 84 | D | -23 | -10 | -19 | -11 | -13 | -10 | -2 | -1 | -2 | -3 | -2 | 10 | 9 | -36 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |